Cannell & Spears’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.66M | Sell |
9,843
-87
| -0.9% | -$14.9K | 0.03% | 208 |
|
|
2025
Q4 | $1.68M | Hold |
9,930
| – | – | 0.03% | 205 |
|
|
2025
Q3 | $1.43M | Hold |
9,930
| – | – | 0.03% | 212 |
|
|
2025
Q2 | $1.26M | Sell |
9,930
-58
| -0.6% | -$7.12K | 0.03% | 214 |
|
|
2025
Q1 | $1.28M | Hold |
9,988
| – | – | 0.03% | 214 |
|
|
2024
Q4 | $1.32M | Hold |
9,988
| – | – | 0.03% | 217 |
|
|
2024
Q3 | $1.45M | Hold |
9,988
| – | – | 0.03% | 209 |
|
|
2024
Q2 | $1.37M | Hold |
9,988
| – | – | 0.03% | 199 |
|
|
2024
Q1 | $1.37M | Hold |
9,988
| – | – | 0.03% | 207 |
|
|
2023
Q4 | $1.36M | Buy |
9,988
+798
| +9% | +$97.4K | 0.11% | 79 |
|
|
2023
Q3 | $1.12M | Hold |
9,190
| – | – | 0.1% | 81 |
|
|
2023
Q2 | $1.17M | Hold |
9,190
| – | – | 0.1% | 84 |
|
|
2023
Q1 | $1.19M | Hold |
9,190
| – | – | 0.11% | 87 |
|
|
2022
Q4 | $1.21M | Hold |
9,190
| – | – | 0.12% | 82 |
|
|
2022
Q3 | $1.07M | Sell |
9,190
-3,000
| -25% | -$373K | 0.11% | 85 |
|
|
2022
Q2 | $1.43M | Hold |
12,190
| – | – | 0.13% | 78 |
|
|
2022
Q1 | $1.59M | Hold |
12,190
| – | – | 0.12% | 80 |
|
|
2021
Q4 | $1.86M | Hold |
12,190
| – | – | 0.13% | 78 |
|
|
2021
Q3 | $1.97M | Sell |
12,190
-377
| -3% | -$63.4K | 0.14% | 69 |
|
|
2021
Q2 | $2.06M | Hold |
12,567
| – | – | 0.15% | 72 |
|
|
2021
Q1 | $1.89M | Hold |
12,567
| – | – | 0.15% | 67 |
|
|
2020
Q4 | $1.9M | Hold |
12,567
| – | – | 0.16% | 67 |
|
|
2020
Q3 | $1.7M | Hold |
12,567
| – | – | 0.16% | 68 |
|
|
2020
Q2 | $1.72M | Buy |
12,567
+58
| +0.5% | +$7.39K | 0.18% | 63 |
|
|
2020
Q1 | $1.35M | Sell |
12,509
-1,195
| -9% | -$138K | 0.16% | 71 |
|
|
2019
Q4 | $1.65M | Hold |
13,704
| – | – | 0.18% | 50 |
|
|
2019
Q3 | $1.36M | Sell |
13,704
-1,860
| -12% | -$195K | 0.16% | 49 |
|
|
2019
Q2 | $1.7M | Hold |
15,564
| – | – | 0.2% | 44 |
|
|
2019
Q1 | $1.74M | Hold |
15,564
| – | – | 0.22% | 41 |
|
|
2018
Q4 | $1.5M | Sell |
15,564
-105
| -0.7% | -$11.1K | 0.22% | 46 |
|
|
2018
Q3 | $1.91M | Buy |
15,669
+105
| +0.7% | +$12.4K | 0.23% | 42 |
|
|
2018
Q2 | $1.71M | Hold |
15,564
| – | – | 0.22% | 42 |
|
|
2018
Q1 | $1.66M | Hold |
15,564
| – | – | 0.22% | 42 |
|
|
2017
Q4 | $1.66M | Buy |
15,564
+240
| +2% | +$25.7K | 0.2% | 44 |
|
|
2017
Q3 | $1.7M | Buy |
15,324
+150
| +1% | +$16K | 0.2% | 46 |
|
|
2017
Q2 | $1.57M | Hold |
15,174
| – | – | 0.19% | 43 |
|
|
2017
Q1 | $1.48M | Buy |
15,174
+870
| +6% | +$83.3K | 0.19% | 43 |
|
|
2016
Q4 | $1.26M | Buy |
+14,304
| New | +$1.3M | 0.16% | 45 |
|
Other funds holding IBB
CB
Cannell & Spears's IBB Position: Q1 2026 in Review
Cannell & Spears reduced its iShares Biotechnology ETF (IBB) stake by 0.88% in Q1 2026, selling an estimated $14.9K and leaving 9,843 shares worth $1.66M. The position accounts for 0.03% of the portfolio, ranked #208.
Cannell & Spears first reported a position in IBB in Q4 2016 and has held it in 38 quarters since. The position peaked at $2.06M in Q2 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Cannell & Spears held 9,843 shares of iShares Biotechnology ETF worth $1.66M as of Q1 2026.
- Cannell & Spears sold 87 iShares Biotechnology ETF shares in Q1 2026, an estimated $14.9K.
- iShares Biotechnology ETF made up 0.03% of Cannell & Spears's portfolio in Q1 2026, its #208 holding.
- Cannell & Spears first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 38 quarters since.
- Cannell & Spears's iShares Biotechnology ETF position peaked at $2.06M in Q2 2021.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.